Decoding 12 Analyst Evaluations For Capricor Therapeutics
Decoding 12 Analyst Evaluations For Capricor Therapeutics
解读12位分析师对capricor therapeutics的评价
The perception...Analysts' ratings for Capricor Therapeutics (NASDAQ:CAPR) over the last quarter vary from bullish to bearish, as provided by 12 analysts.
分析师对于Capricor therapeutics（纳斯达克：CAPR）在过去一个季度的评级从看好到看淡不等，来自12位分析师的提供。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
Analysts have set 12-month price targets for Capricor Therapeutics, revealing an average target of $31.67, a high estimate of $77.00, and a low estimate of $8.00. Observing a 33.46% increase, the current average has risen from the previous average price target of $23.73.
分析师们为capricor therapeutics设定了12个月的价格目标，显示出平均目标为31.67美元，最高估计为77.00美元，最低估计为8.00美元。观察到33.46%的增长，当前平均价格目标已经从之前的23.73美元上升。
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
The perception...
金融...
登录免费看全文
登录/注册
资讯热榜
更新时间